TorrentFreak

DECEMBER 17, 2023

Running for four seasons from the 2025-26 campaign, the deal will see broadcasters Sky and TNT take the live games and the BBC continue with its popular highlights package. Amazon, which has been licensing Premier League games since 2019, hoping to drive customers towards its Prime service, wasn’t awarded a single match.

Licensing 124

Licensing Copyright Marketing Marketing 124

LexBlog IP

DECEMBER 13, 2023

The post Janssen and Samsung Bioepis Settle STELARA (Ustekinumab) Litigation appeared first on Big Molecule Watch.

Litigation 52

Litigation Settlement Licensing Marketing 52

SpicyIP

OCTOBER 1, 2024

The firm has also ventured into Domain disputes, Licensing, Investigations and Litigations and is currently handling litigations in various forums in the country and abroad. Prepare candidates to qualify for the Indian Patent Agent Examination (Paper I and Paper II) to be held in the year 2025. Majumdar & Co.,

Registration 103

Registration Intellectual Property IP Patent Drafting 103

The IPKat

AUGUST 13, 2024

Upcoming events Assimilate IP Autumn Courses and Webinars : Protecting Confidential Information, Trade Secrets and Know How : 11 September 2024 Freedom to Operate for Life Sciences and Pharma : 25 & 26 September 2024 Patent and Know How Licensing : 9 & 10 October 2024 IP Essentials – Patent or Trade Secret? Call for abstracts.

Intellectual Property 62

Intellectual Property IP Journalism Confidentiality 62

LexBlog IP

JUNE 13, 2023

announced that they reached a settlement and license agreement with Johnson & Johnson regarding AVT04, Alvotech’s proposed biosimilar to STELARA (ustekinumab) in the United States. Alvotech and Teva Pharmaceuticals, Inc.

Settlement 52

Settlement Marketing Marketing Licensing 52

LexBlog IP

AUGUST 16, 2023

In February 2023, Formycon announced its entry into a global license agreement with Fresenius Kabi to commercialize FYB202 in key global markets after successful regulatory approvals. According to the press release, Formycon plans to submit a biologics license application later in 2023 to seek regulatory approval for FBY202.

Settlement 52

Settlement Licensing Confidentiality Marketing 52

The Trichordist

OCTOBER 14, 2024

The fight over frozen mechanicals continues to pay off as songwriters log another cost of living increase for physical/downloads while streaming falls farther behind.

Licensing 62

Licensing Copyright 62

IAM Magazine

SEPTEMBER 23, 2021

A new high-level policy calls for growth by a metric that includes not just royalty receipts but also payments to foreign IP owners.

IP 52

IP Marketing Marketing Licensing 52

LexBlog IP

JANUARY 12, 2023

Coherus plans to file an abbreviated Biologics License Application (aBLA) with the FDA later this year and intends to launch the product at EYLEA biosimilar market formation, currently expected to be in 2025. The parties expect to complete the transaction in Q1 2023.

Marketing 52

Marketing Marketing Licensing Intellectual Property 52

Kluwer Copyright Blog

JUNE 20, 2024

The privacy policy of WhatsApp does not seem affected, even if new AI tools are in development also for this service. Even other internet service providers are currently facing similar issues and had to provide certain clarifications.

Privacy 117

Privacy Copyright Technology Licensing 117

LexBlog IP

MARCH 6, 2024

On February 29, Biocon Biologics Ltd announced that it signed a settlement and license agreement with Janssen Biotech Inc. The agreement allows Biocon to launch in the United States in February 2025, pending FDA approval. Amgen secured a U.S. The post Biocon Settles with Janssen, Securing U.S.

Marketing 40

Marketing Marketing Settlement Licensing 40

The IPKat

SEPTEMBER 28, 2024

Forthcoming events and call for papers WIPO has launched the 2025–2026 Training, Mentoring, and Matchmaking Program on Intellectual Property for Women Entrepreneurs from Indigenous Peoples and Local Communities in Pacific Island countries. As autumn has begun, the IP world is buzzing with events, opportunities and news: don’t miss them!

Intellectual Property 67

Intellectual Property Social Media Intellectual Property Law IP 67

The IPKat

MARCH 24, 2024

The new edition of the programme will start in January 2025 and the deadline for applications is 31 May 2024. Forthcoming events On 2 May 2024 University College London (UCL) will host a Seminar on Collective Licensing and a Workshop on Copyright Solutions jointly organized with EODOPEN. Additional information available here.

Intellectual Property 62

Intellectual Property Journalism Intellectual Property Law Registration 62

Velocity of Content

MAY 25, 2023

The agreement enables MARC to include CCC’s comprehensive rights catalog in the licenses it offers to educational and academic institutions in Malaysia. MARC is an independent, not-for-profit organization acting as a collective licensing organization on behalf of publishers, authors, and visual creators in Malaysia.

Licensing 52

Licensing Journalism Copyright Marketing 52

Herbert Smith Freehills

OCTOBER 14, 2021

"Abbisko is dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies and has strategically designed and developed a diversified pipeline of 12 programs with global R&D and commercialisation rights and selectively in-licensed two programs.". from 2025 to 2030. HK?????????06609.HK????????06669.HK??.

Marketing 52

Marketing Marketing Licensing Publishing 52

LexBlog IP

AUGUST 30, 2023

market on March 7, 2025, if approved by FDA. J&J also recently filed a confidential settlement and license agreement to terminate a Samsung Bioepis challenge to all claims of U.S.

Settlement 40

Settlement Confidentiality Marketing Marketing 40

Bio Law Blog

JUNE 21, 2020

settled three Inter Partes Review (IPR) proceedings concerning patents covering Alexion’s blockbuster humanized monoclonal antibody drug Soliris®, with Amgen obtaining a royalty-free license for marketing a biosimilar prior to expiration of the patents at issue. and Alexion Pharmaceuticals Inc. an eculizumab product.

Marketing 52

Marketing Marketing Settlement Patent 52

SpicyIP

JULY 8, 2024

CGPDTM Announces Dates for 2025 Trademark and Patent Agent Exams Dates for Trademark and Patent Agent Exams 2025 have been announced by the CGPDTM. The Trademark Agent Exam is likely to be held on January 04, 2025 and the Patent Agent Exam is likely to be held on January 5, 2025. Microsoft Technology Licensing LLC v.

Invention 59

Invention Art Trademark Patent Application 59

The IPKat

DECEMBER 31, 2023

The position includes supporting the head of global health at WIPO to implement special projects on IP-related to access to medical technologies, patent litigation, one health AMR, AI for health, licensing, technology transfer and local manufacturing. The whole editorial is available here.

Intellectual Property 70

Intellectual Property Intellectual Property Law Public Domain Copyright Infringement 70

The IPKat

SEPTEMBER 8, 2024

Vacancies Maynooth University is currently recruiting a Post-Doctoral Researcher and a Research Assistant for a research project that investigates the role of bioethics in the patenting and licensing of technologies related to the human body. Closing dates for the applications are, respectively, 26 and 22 September.

Intellectual Property 57

Intellectual Property Registration Copyright Licensing 57

The IPKat

OCTOBER 4, 2023

Unfortunately, this rule will come into effect only on 1 February 2025. Picture is by EVG Kowalievska and licensed under the licensing terms of Pexels.com. Further, member states of the Madrid Protocol can delay the effectiveness by notifying WIPO and there is no ultimate deadline (Rule 40(8) Regulations).

Licensing 76

Licensing Registration Law 76

The IPKat

DECEMBER 17, 2024

The consultation runs until 25 February 2025. The consultation is likely to elicit strong views from both sides of the debate; some rightsholders will be dismayed at the potential weakening of their rights in a very important market for creators, whereas AI developers will want to know how any proposals will apply in practice.

Copyright 62

Copyright Government Personality Rights IP 62

TorrentFreak

DECEMBER 3, 2024

The DISH complaint described Jadoo TV’s operation as a “deliberate, multi-year effort” to distribute its exclusively-licensed TV channels without authorization, amounting to direct, contributory, and vicarious infringement under 17 U.S.C. 20, 2025,” the statement reads. Section 501.

Copyright Infringement 58

Copyright Infringement Settlement Copyright Litigation 58

IAM Magazine

SEPTEMBER 23, 2021

A new high-level policy calls for growth by a metric that includes not just royalty receipts but also payments to foreign IP owners.

IP 40

IP Marketing Marketing Licensing 40

LexBlog IP

APRIL 17, 2023

Xolair’s substance patent has already expired and the formulation patent is set to expire in March 2024 in Europe and November 2025 in the U.S. Celltrion said that it “plans to complete the remaining phase 3 studies of CT-P39 and file for product license in Korea and key other countries later this year.”

Licensing 40

Licensing Patent Intellectual Property 40

The IPKat

FEBRUARY 29, 2024

Sony maintains that the worldwide copyright for the recordings is held by Experience Hendrix LLC and Authentic Hendrix LLC, who license the rights to exploit and distribute the recordings to them. It is likely therefore that it will stand to be determined by a High Court judge some time in 2025.

Copyright 109

Copyright Reporting Contracts Settlement 109

The IPKat

APRIL 22, 2024

Accredited European Patent Litigation Certificate Course Trier & Online tutorial - Course start: 25 September 2024; Course end: 16 May 2025 ERA will offer a high-standard course giving patent attorneys the best tools to understand the legal framework and procedural rules necessary to litigate before the UPC.

Intellectual Property Law 62

Intellectual Property Law Intellectual Property IP Litigation 62

Velocity of Content

OCTOBER 29, 2024

Like hiking through unfamiliar woods without a map, campers noted that policies vary between funders, are ever-changing, and difficult to locate, let alone understand. Campers expressed that most authors’ questions relate to copyright license selection and article processing charge (APC) funding.

Publishing 52

Publishing Journalism Licensing Copyright 52

LexBlog IP

SEPTEMBER 28, 2023

has announced an exclusive licensing agreement with Tonghua Dongbao Pharmaceuticals Co., According to the press release, the first molecules subject to the agreement are expected to launch as early as 2025. Insulin Biosimilars: Meitheal Pharmaceuticals, Inc. Anti-Tumor Biosimilars: Chime Biologics Ltd.,

Marketing 40

Marketing Marketing Contracts Registration 40

IP Tech Blog

MAY 19, 2023

billion by 2025, at a compound annual growth rate of 32%. Contracts should explicitly address the ownership, licensing, and usage rights of content created during the collaboration, which will vary depending on the commercial arrangement. billion in 2020 to $24.1 A brand should also obtain waiver of moral rights from the influencer.

Marketing 57

Marketing Marketing Contracts Branding 57

SpicyIP

MARCH 15, 2024

This post does not, in any manner, get into the arena of willingness or unwillingness of defendants to enter into a licensing agreement. If the trial spills over to 2025, the defendants will have to bear the cost for that as well. I pose questions (rather than offer comments) with regard to the Court’s approach on bank guarantees.

Patent Infringement 59

Patent Infringement Settlement Patent Licensing 59

SpicyIP

OCTOBER 27, 2024

Call for Papers: NLU Jodhpur’s Journal of Intellectual Property Studies Volume IX, Issue I [Submit by January 10, 2025] National Law University, Jodhpur’s Journal of Intellectual Property Studies is inviting original, unpublished manuscripts for its upcoming issue (Volume IX, Issue I). The last date for submissions is January 10, 2025.

Trademark 103

Trademark Copyright Cease and Desist Registration 103

Kluwer Copyright Blog

DECEMBER 17, 2024

There is a shared interest in ensuring that AI companies have legal routes to license content in the quantity required by this revolutionary technology. They would hopefully shape an open-minded and balanced approach in licensing, legislating, policy-making, publishing and researching.

Publishing 52

Publishing Reporting Branding Brands 52

LexBlog IP

DECEMBER 28, 2023

Reddy’s”) to license Dr. Reddy’s proposed biosimilar abatacept for the development and commercialization of COYA 302 for the treatment of neurodegenerative conditions. Coherus intends to launch the product at EYLEA biosimilar market formation, currently expected to be in 2025, if approved.

Licensing 40

Licensing Reporting Marketing Marketing 40

LexBlog IP

MAY 19, 2023

billion by 2025, at a compound annual growth rate of 32%. Contracts should explicitly address the ownership, licensing, and usage rights of content created during the collaboration, which will vary depending on the commercial arrangement. billion in 2020 to $24.1 A brand should also obtain waiver of moral rights from the influencer.

Marketing 52

Marketing Marketing Contracts Branding 52

LexBlog IP

JANUARY 16, 2023

The European Commission expressed its hope that the provisions of the regulation will enter into force across all EU member states in 2025. If approved, the EHDS proposal would introduce a new regime for the compulsory licensing of health data to third parties.

Intellectual Property 52

Intellectual Property Confidentiality Business Advertising 52

Kluwer Copyright Blog

JUNE 2, 2024

En route to a planned roll-out in 2025 the company will collaborate with relevant stakeholders. OpenAI adds that new features will be added in the future. With Media Manager in development one can only speculate what opportunities it will bring for authors and rightholders.

Contracts 78

Contracts Copyright Publishing Business 78